Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatoblastoma.

G Calderwood, D L Nguyen, J C Leonard

    Clinical Nuclear Medicine
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Hepatoblastoma, a rare childhood liver cancer, often presents as an abdominal mass. Early detection and complete surgical removal are crucial for improving the survival rate, which is currently 35% post-resection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of Prehospital Pain Management on Emergency Department Management of Injured Children.

    Prehospital emergency care·2021
    Same author

    A survey of US and Canadian hospitals' paediatric massive transfusion protocol policies.

    Transfusion medicine (Oxford, England)·2016
    Same author

    Pancreatic β-cell imaging in humans: fiction or option?

    Diabetes, obesity & metabolism·2015
    Same author

    Yale Case Studies: Agranulocytic Angina.

    The Yale journal of biology and medicine·2011
    Same author

    Bacteriostatics employed and medical problems.

    Occupational medicine·2010
    Same author

    The diagnostic clinic.

    Connecticut state medical journal·2010
    Same journal

    Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.

    Clinical nuclear medicine·2026
    Same journal

    A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer.

    Clinical nuclear medicine·2026
    Same journal

    Epileptogenic Brain Metastasis Early Positive on 18FDG PET/CT Compared to MRI.

    Clinical nuclear medicine·2026
    Same journal

    Dural Manifestation of Langerhans Cell Histiocytosis​: Multimodality Imaging Approach.

    Clinical nuclear medicine·2026
    Same journal

    Malignant Perivascular Epithelioid Cell Tumor (PEComa) of Left Adrenal Gland With Extensive Intravenous Tumor Thrombi: 18F-FDG PET/CT Findings.

    Clinical nuclear medicine·2026
    Same journal

    18F-MFBG Uptake From Multiple Focal "Hot Spots" to Superscan in a Pediatric Patient With High-risk Neuroblastoma.

    Clinical nuclear medicine·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Hepatobiliary Diseases
    • Tumor Markers

    Background:

    • Hepatoblastoma is a rare malignant liver tumor predominantly affecting infants and young children.
    • It typically manifests as a rapidly growing abdominal mass within the first three years of life.

    Observation:

    • Clinical presentation often includes a palpable abdominal mass; other symptoms can be nonspecific.
    • Associated conditions may include hemihypertrophy, virilization, and osteoporosis.
    • Elevated serum alpha-fetoprotein (AFP) is a common tumor marker, observed in up to two-thirds of cases.

    Findings:

    • Serum bilirubin levels are infrequently elevated in hepatoblastoma.
    • Complete surgical resection is the primary curative treatment modality.
    • The overall survival rate for patients undergoing complete resection is approximately 35%.

    Related Experiment Videos

    Implications:

    • Early diagnosis and surgical intervention are critical for improving outcomes in hepatoblastoma.
    • Serum AFP serves as a valuable biomarker for monitoring disease status.
    • Further research into novel therapeutic strategies is warranted to enhance survival rates for this rare pediatric malignancy.